SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development CRL Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Utility Performance Intellia Therapeutics NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Market Optimism STRRP Q1 2026 Earnings Preferred Stock Reports Sharp EPS Miss Yet Shares Gain REKR Q1 2026 Earnings EPS Misses Estimates Revenue Data Unavailable